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Abstract: The measurement of folate in red blood cells (RBCs) is preferred since it reﬂ  ects long-term folate status in the 
body compared to plasma/serum folate which may be inﬂ  uenced by recent dietary intake. The commonly accepted technique 
for RBC folate analysis involves preparation of a hemolysate using a fresh whole blood sample. Hematocrit and plasma 
folate concentrations are needed to calculate RBC folate values. Because of the need for immediate access to a laboratory 
where processing can be performed, it may not be practical to assess RBC folate status using this method in ﬁ  eld-based 
epidemiological studies. It is however, feasible to isolate packed RBSs from a blood sample under these conditions. The 
purpose of this study is to validate RBC folate analysis using packed red cells by comparing the RBC folate values obtained 
by hemolysate method (routine assay) with those obtained by using packed RBCs (new assay) in the same individuals 
(n = 50) using the folate microbiological assay. The correlation between plasma folate and the routine RBC folate assay 
(r = 0.58, p = 0.001) and the correlation between plasma folate and the new RBC folate assay was statistically signiﬁ  cant 
(r = 0.55, p = 0.001). The correlation between RBC folate by the routine assay and new assay was also statistically signiﬁ  -
cant (r = 0.78, p  0.001). We conclude that measurement of folate in packed RBC is a practical approach in assessing 
long-term folate status in ﬁ  eld-based and or larger scale epidemiological studies where an immediate access to a laboratory 
is unavailable for necessary sample processing for the routine RBC folate assay.
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Introduction
Circulating blood folate analysis has been the routine diagnostic test for folate deﬁ  ciency for over three 
decades. Assessment of folate status has also been important because of its role in reducing the risk for 
cardiovascular disease [1], neural tube defects [2] and cancers [3]. The measurement of folate in red 
blood cells (RBCs) is preferred since it reﬂ  ects long-term folate status in the body compared to plasma/
serum folate which may be inﬂ  uenced by recent dietary intake [4]. The commonly accepted technique 
for RBC folate analysis involves preparation of a hemolysate using fresh whole blood by diluting it in 
freshly prepared 1% ascorbate. Incubation of the hemolysate at 37 ºC for 20 minutes allows endogenous 
plasma conjugase (gamma-glutamyl carboxypeptidase) to convert RBC folate polyglutamates to assay-
able folates. Because of the need for immediate access to a laboratory where hemolysates can be prepared 
appropriately, it may not be practical to assess RBC folate status in ﬁ  eld-based epidemiological studies. 
It is however, feasible to isolate packed red blood cells from a blood sample under these conditions. 
The purpose of this study is to validate RBC folate analysis using packed red cells by comparing the 
RBC folate values obtained by hemolysate method with those obtained by using packed RBCs in the 
same individuals.
Materials and Methods
We used 50 randomly selected samples which were processed and stored from a large study where all 
study participants gave permission to use their samples in future studies related to cancer research. 
These samples had been collected over a 12-month period. All these samples were immediately processed 
and stored appropriately to assess plasma and RBC folate by using a RBC hemolysate method. Brieﬂ  y, 
a 10 ml blood sample was collected into one EDTA (purple top) vacutainer tube. The hematocrit (needed 
to calculate RBC folate concentrations) was measured using 25 µl of whole blood. After mixing 25 µl 
of whole blood with 725 µl of freshly prepared 1% ascorbate for the RBC folate assay, the remainders 
of the whole blood samples were centrifuged at 3000 rpm for 10 minutes to separate plasma from RBCs. 108
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Plasma was transferred to a separate tube and 
stored at −80 ºC until used for folate analysis. Buffy 
coat was taken off carefully to remove all white 
blood cells from the sample. The packed red cells 
were transferred to a centrifuge tube and stored at 
−80 ºC until used for future assays. In this study, 
we used plasma, RBC hemolysate and packed 
RBCs for folate analysis from the selected indi-
viduals.
Preparation of RBCs for Folate 
Analysis
When freshly collected blood samples were used 
for RBC folate assay, the conversion of RBC folate 
polyglutamates to monoglutamates was achieved 
enzymatically by plasma folate conjugase after 
incubating the hemolysate (prepared by mixing 25 
µl of whole blood with 725 µl of freshly prepared 
1% ascorbic acid) at 37 ºC for 20 minutes. Rat 
plasma was used as a source of conjugase to convert 
folate polyglutamates to monoglutamates in packed 
RBCs. Rat plasma (Harland Bioproducts for 
Science, Catalog # BT-4511) was treated with acti-
vated charcoal (Sigma, Catalog # C-4386)) to 
remove folate; 750 mg of charcoal per 15 ml of rat 
plasma was stirred very gently for 60 minutes on 
ice and centrifuged at 3500 rpm at 4 °C for 5 min-
utes. The supernatant was ﬁ  ltered through a 0.22 
micron ﬁ  lter. After the rat plasma was tested for 
folate to make sure that it is free of folate, aliquots 
were made and stored at −70 °C. Initial experiments 
indicated that optimal conversion of folate polyglu-
tamates in RBC samples can be achieved by mixing 
25 µl of packed RBCs with 712.5 µl of freshly 
prepared 1% ascorbic acid and 12.5 µl of rat plasma 
(charcoal stripped) and by incubating the mixture 
at 37 ºC for 30 minutes. All packed red cell samples 
were prepared following this protocol.
L. casei Microbiological Assay
The 96-well plate adaptation of L. casei microbio-
logical assay was used to measure the total folate 
levels in the appropriately treated samples of RBC 
and plasma [5,6,7]. Brieﬂ  y, 20 µl of sample and 
folate standard (15 ng/ml) was used in the assay. 
The volumes of the sample and of the standard 
were adjusted to 300 µl using 0.1 M phosphate 
buffer (pH 8.6) containing 10 mg/ml of ascorbic 
acid. Six serial dilutions of sample and standard 
(folate standards in the range of 0.005 to 0.15 ng/0.3 
ml assay well after serial dilutions) were made 
using a 12-channel pipetter. Then 150 µl of L. casei 
medium containing L. casei, at a concentration of 
5 µl/10 ml of medium) was pipetted into all wells 
and incubated for 18 hours at 37 ºC. After incuba-
tion, the contents of each well were suspended by 
repeated aspiration and ﬂ  ushing several times with 
a 12-channel pipetter. Bacterial growth was mea-
sured by reading the optical density at 655 nm. 
This assay is based on the ability of the folate in 
the sample to stimulate Lactobacillus casei (ATTC 
7469) growth relative to folate-containing stan-
dards. The coefﬁ  cient of variation and recovery of 
this assay are 5%–7% and 96%–105% respectively. 
To monitor the reproducibility of these assays, two 
pooled samples (low and high) prepared from 
plasma obtained from the American Red Cross was 
assayed at least 30 times and the means and stan-
dard deviations were determined. These served as 
the basis for the quality control for the assays (the 
study sample assays were repeated if the values of 
the control samples in each run were beyond two 
standard deviations from the mean). The low and 
high pools were included in every plate. Plasma, 
RBC hemolysate and packed RBC preparations 
from the same individuals were assayed for folate 
under the same experimental conditions (same 
plate, same day, etc).
Calculation of RBC Folate
The following formula was used to calculate RBC 
folate when the routine assay was used.
Whole blood folate (ng/ml) – [Plasma folate ng/ml 
(1-hematocrit/100) ]
Hematocrit/100
This formula makes a correction for plasma folate 
present in the whole blood hemolysate and for the 
proportion of blood that consists of RBC. Since 
packed red cells are used in the new assay, a cor-
rection for plasma folate or hematocrit is not 
required in the new assay. The rat plasma used in 
this assay was charcoal stripped and was tested to 
have no detectable folate.
In addition, the experiment described below was 
performed to evaluate whether the efﬁ  ciency of rat 
plasma conjugase is different from that of the 
human plasma conjugase. To conduct this experiment, 
blood samples drawn from six individuals were 
centrifuged at 3000 rpm/10 minutes. The plasma 109
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and buffy coat were removed to isolate RBC. Two 
aliquots of RBC from each sample were treated 
with rat plasma or human plasma from each indi-
vidual as described previously.
An additional experiment was also conducted 
to determine whether the removal of buffy coat 
makes a difference in RBC folate values. Blood 
samples from six individuals drawn in duplicate 
tubes (5 ml each) were used in these experiments. 
All tubes were centrifuged at 3000 rpm/10 minutes. 
Plasma was removed from one tube from each 
individual leaving buffy coat and packed red cells. 
From the other set of tubes, plasma and buffy coat 
was removed leaving only the packed red cells. 
RBC with or without buffy coat was treated with 
rat plasma as described previously.
Statistical Analysis
Descriptive statistics such as mean, median, stan-
dard deviation (SD) of the mean, and range were 
computed to examine the differences between the 
RBC hemolysate method (routine) and RBC 
packed cell method (new). Wilcoxon Signed Rank 
test was employed to determine the statistical sig-
niﬁ  cance of the differences between folate results 
obtained by the routine and new techniques. The 
differences between folate values due to the use of 
rat plasma or human plasma or the differences in 
folate values due to removal or leaving the buffy 
coat were tested with similar statistical tests. Non-
parametric (Spearman) correlation analyses were 
employed to determine the association between 
folate results of routine and new techniques
Results
The mean ± SD and median of RBC folate by the 
routine assay was 449 ± 216 ng/ml and 399 ng/ml. 
The mean ± SD and median of RBC folate by the 
new assay was 366 ± 188 ng/ml and 309 ng/ml. 
The difference between the two assays was statis-
tically signiﬁ  cant (p  0.001, Wilcoxon Signed 
Rank Test). In 43 samples, the RBC folate values 
were higher with the routine assay compared to the 
new assay and 7 samples had higher RBC folate 
values with the new assay compared to the routine 
assay. Over all, with 43 samples, RBC folate values 
were 23% lower with the new assay compared to 
the routine assay. With 7 samples, RBC folate 
values were 10% higher with the new assay 
compared to the routine assay. The higher or lower 
RBC values by the new technique compared to the 
routine technique were distributed unevenly in the 
data set. There was no inverse association between 
the lengths of storage of samples over 12 months 
folate values to indicate that longer storage time 
may yield lower RBC folate values by the new 
technique. The correlation between plasma folate 
and the routine RBC folate assay (r = 0.58, 
p = 0.001) and the correlation between plasma 
folate and the new RBC folate assay was statisti-
cally signiﬁ  cant (r = 0.55, p = 0.001). The correla-
tion between RBC folate by the routine assay and 
new assay was also statistically signiﬁ  cant (r = 0.78, 
p  0.001, Figure 1).
On average, the RBC folate values of samples 
treated with rat plasma were 24% lower compared 
to the RBC values of samples treated with human 
plasma and this difference was statistically sig-
niﬁ  cant (p = 0.03). RBC folate values of samples 
with buffy coat had slightly higher folate values 
compared to RBC samples without buffy coat, but 
the difference between the two was not statistically 
signiﬁ  cant (p = 0.27).
Discussion
Folate values can be measured using either a 
serum/plasma folate or a red cell folate assay. A 
negative folate balance seen in hospital patients 
are shown to result in a low serum folate value 
without folate deﬁ  ciency [8]. Therefore, low red 
cell folate, thought to indicate tissue deﬁ  ciency, 
may be more important than a low serum folate in 
the diagnosis of folate deﬁ  ciency. Longer term 
folate status is also likely to be more informative 
in assessing its importance in chronic diseases such 
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Figure 1. Correlation between RBC folate measured by the routine 
assay and the new assay.110
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as cancerous or pre cancerous conditions. We 
recently reported that a combined measure of RBC 
and plasma folate status is a much stronger predic-
tor for the natural history (acquisition, persistence 
or clearance of high risk human papilloma virus, 
the main risk factor for CIN and cervical cancer 
than plasma folate alone [9]. These observations 
suggest that assessment of RBC folate status is 
important in ﬁ  eld-based epidemiological studies. 
However, the need for immediate access to a labo-
ratory where hematocrit could be measured and 
hemolysates can be prepared appropriately is an 
obstacle for using the routine RBC folate assay in 
ﬁ  eld-based epidemiological studies. For this rea-
son, samples are not available to assess RBC folate 
status in most currently available biorepositories 
of epidemiological studies Also, the routine RBC 
folate calculation requires the value for plasma 
folate which increases the cost for RBC folate 
assessment in larger scale studies. RBC folate 
assessment using packed RBC described in this 
manuscript eliminates some of these limitations. 
We also document that RBCs can be stored with 
or without buffy coats and folate is stable in these 
samples for a 12-month period. We noted that RBC 
folate concentrations in a given sample is likely to 
be lower when rat plasma was used to convert RBC 
folate polyglutamates to monoglutamates com-
pared to human plasma and this may be due to 
lower efﬁ  ciency of rat plasma in converting human 
RBC polyglutamates to monoglutamates. This 
should not however, interfere with data interpreta-
tion as long as rat plasma is used with all samples 
in a given study. We have used this newly devel-
oped RBC folate assay in a large epidemiological 
study where we conﬁ  rmed that the relationship 
between a polymorphism in the folate pathway and 
folate concentrations are similar when folate was 
measured using the new assay and the routine folate 
assay which used a whole blood hemolysate [10]. 
In conclusion, we document that measurement of 
folate in packed RBC is a practical approach in 
assessing long-term folate status in ﬁ  eld-based and 
or larger scale epidemiological studies.
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